Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Martin Beaulieu

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Journal of Psychiatry & Neuroscience : JPN|June 30, 2011
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthJean-Martin Beaulieu
Journal of Neurochemistry|October 19, 2016
Converging evidence for regulation of dopamine neurotransmission by lithium: An Editorial Highlight for 'Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens'Jean-Martin Beaulieu
Methods (San Diego, Calif.)|September 1, 2015
In vivo veritas, the next frontier for functionally selective GPCR ligandsJean Martin Beaulieu
Pharmacological Research|December 12, 2018
A fresh look at cortical dopamine D2 receptor expressing neuronsClémentine Quintana, Jean-Martin Beaulieu
Medecine Sciences : M/S|July 13, 2010
[Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses]Thomas Del'Guidice, Jean-Martin Beaulieu
The CRISPR Journal|June 26, 2020
CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor-Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional RegulationJivan Khlghatyan, Jean-Martin Beaulieu
Progress in Molecular Biology and Translational Science|June 15, 2013
β-Arrestins in the central nervous systemCamille Latapy, Jean Martin Beaulieu
Frontiers in Molecular Neuroscience|February 25, 2012
Inhibition of GSK3 by lithium, from single molecules to signaling networksLaure Freland, Jean-Martin Beaulieu
Molecular Pharmacology|March 4, 2008
Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivoThomas Del'guidice, Jean-Martin Beaulieu
Frontiers in Synaptic Neuroscience|August 9, 2018
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?Jivan Khlghatyan, Jean-Martin Beaulieu
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Psychiatry & Neuroscience : JPN|June 30, 2011
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthJean-Martin Beaulieu
Journal of Neurochemistry|October 19, 2016
Converging evidence for regulation of dopamine neurotransmission by lithium: An Editorial Highlight for 'Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens'Jean-Martin Beaulieu
Methods (San Diego, Calif.)|September 1, 2015
In vivo veritas, the next frontier for functionally selective GPCR ligandsJean Martin Beaulieu
Pharmacological Research|December 12, 2018
A fresh look at cortical dopamine D2 receptor expressing neuronsClémentine Quintana, Jean-Martin Beaulieu
Medecine Sciences : M/S|July 13, 2010
[Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses]Thomas Del'Guidice, Jean-Martin Beaulieu
The CRISPR Journal|June 26, 2020
CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor-Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional RegulationJivan Khlghatyan, Jean-Martin Beaulieu
Progress in Molecular Biology and Translational Science|June 15, 2013
β-Arrestins in the central nervous systemCamille Latapy, Jean Martin Beaulieu
Frontiers in Molecular Neuroscience|February 25, 2012
Inhibition of GSK3 by lithium, from single molecules to signaling networksLaure Freland, Jean-Martin Beaulieu
Molecular Pharmacology|March 4, 2008
Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivoThomas Del'guidice, Jean-Martin Beaulieu
Frontiers in Synaptic Neuroscience|August 9, 2018
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?Jivan Khlghatyan, Jean-Martin Beaulieu
Pageof 9